1. Home
  2. CJET vs GANX Comparison

CJET vs GANX Comparison

Compare CJET & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CJET
  • GANX
  • Stock Information
  • Founded
  • CJET 2009
  • GANX 2017
  • Country
  • CJET China
  • GANX United States
  • Employees
  • CJET N/A
  • GANX N/A
  • Industry
  • CJET Auto Manufacturing
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CJET Consumer Discretionary
  • GANX Health Care
  • Exchange
  • CJET Nasdaq
  • GANX Nasdaq
  • Market Cap
  • CJET 50.7M
  • GANX 51.8M
  • IPO Year
  • CJET N/A
  • GANX 2021
  • Fundamental
  • Price
  • CJET $2.62
  • GANX $1.69
  • Analyst Decision
  • CJET
  • GANX Strong Buy
  • Analyst Count
  • CJET 0
  • GANX 5
  • Target Price
  • CJET N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • CJET 10.6K
  • GANX 304.5K
  • Earning Date
  • CJET 08-05-2025
  • GANX 08-07-2025
  • Dividend Yield
  • CJET N/A
  • GANX N/A
  • EPS Growth
  • CJET N/A
  • GANX N/A
  • EPS
  • CJET N/A
  • GANX N/A
  • Revenue
  • CJET $6,915,000.00
  • GANX N/A
  • Revenue This Year
  • CJET N/A
  • GANX N/A
  • Revenue Next Year
  • CJET N/A
  • GANX N/A
  • P/E Ratio
  • CJET N/A
  • GANX N/A
  • Revenue Growth
  • CJET N/A
  • GANX N/A
  • 52 Week Low
  • CJET $1.09
  • GANX $0.89
  • 52 Week High
  • CJET $4.41
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • CJET 59.90
  • GANX 48.21
  • Support Level
  • CJET $2.27
  • GANX $1.55
  • Resistance Level
  • CJET $2.77
  • GANX $1.72
  • Average True Range (ATR)
  • CJET 0.30
  • GANX 0.13
  • MACD
  • CJET 0.01
  • GANX 0.00
  • Stochastic Oscillator
  • CJET 74.58
  • GANX 40.24

About CJET Chijet Motor Company Inc.

Chijet Motor Co Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: